Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
Article 2021 en
Authors
ML
Michalis Liontos
ET
Evangelos Terpos
CM
Christos Markellos
Abstract
1 min read
These results suggest that maintaining precautions against COVID-19 is essential for cancer patients and should be taken into consideration for the patients under treatment, while further exploration is needed to reduce the uncertainty of SARS-CoV-2 immunity among cancer patients under treatment.
Chelsea Carle, Suzanne Hughes, Victoria Freeman, Denise Campbell, Sam Egger, Michael Caruana, Harriet Hui, Sarsha Yap, Silvia Deandrea, Tonia C. Onyeka, Maarten J. IJzerman, Ophira Ginsburg, Freddie Ian Bray, Richard Sullivan, Ajay Aggarwal, Stuart Peacock, Kelvin Chan, Timothy P. Hanna, Isabelle Soerjomataram, Dianne L. O’Connell, Karen Canfell, Julia Steinberg
Discussion(0)
No comments yet. Be the first to comment.